This content is created by Smallcaps Authors. [Author : Lorna Nicholas]
Australian biotech InhaleRx (ASX: IRX) has made “important progress” in the development of its novel inhaled drug formulations for complex regional pain syndrome (CRPS) and panic disorder. CRPS is described as a chronic pain syndrome with paroxysmal breakthrough pain, which needs immediate pain relief to manage. Similarly, panic disorder, which causes sudden overwhelming anxiety symptoms […]
The post InhaleRx makes ‘important progress’ in inhaled cannabinoid drugs for CRPS and panic disorder appeared first on Small Caps.
from Small Caps https://ift.tt/uXTDUBy
إرسال تعليق